| 1 |
34672241 | Inferior outcomes with R-CEOP for patients with diffuse large B-cell lymphoma and cardiovascular comorbidities. | 2022 Mar |
1 |
| 2 |
34668281 | Diagnosis, management and follow up of peripheral T cell lymphomas: A Consensus Practice Statement from the Australasian Lymphoma Alliance. | 2021 Oct 20 |
1 |
| 3 |
33275671 | Transformed lymphoma: what should I do now? | 2020 Dec 4 |
1 |
| 4 |
30209556 | Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China. | 2019 Jan |
1 |
| 5 |
29380942 | Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas. | 2018 Sep |
1 |
| 6 |
29674443 | Recent Advances in the Treatment of Peripheral T-Cell Lymphoma. | 2018 Sep |
1 |
| 7 |
29877250 | [Treatment of NK/T-cell lymphoma: current situations and prospectives]. | 2018 |
1 |
| 8 |
27960150 | Bendamustine and Rituximab: Complete Response in a 62-Year-Old Female with an Aggressive Lymphoma and an Ejection Fraction of 20. | 2017 |
1 |
| 9 |
28115372 | Peripheral T-cell lymphoma, not otherwise specified. | 2017 Mar 2 |
1 |
| 10 |
29263552 | Primary Cutaneous B-cell Lymphomas: Case Report of Two Cases. | 2017 Nov-Dec |
1 |
| 11 |
29279550 | Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. | 2017 |
2 |
| 12 |
26809026 | Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin. | 2016 |
1 |
| 13 |
27045839 | Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells. | 2016 |
1 |
| 14 |
27351173 | Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma. | 2016 Oct 15 |
1 |
| 15 |
25869285 | The biology and management of systemic anaplastic large cell lymphoma. | 2015 Jul 2 |
1 |
| 16 |
24781973 | The endoplasmic reticulum stress markers GRP78 and CHOP predict disease-free survival and responsiveness to chemotherapy in breast cancer. | 2014 Jun |
1 |
| 17 |
24313062 | [A case of angioimmunoblastic T-cell lymphoma arising in the cervical region]. | 2013 Oct |
1 |
| 18 |
22440390 | Anaplastic large cell lymphoma, ALK-positive. | 2012 Aug |
1 |
| 19 |
22475637 | Lymphoma of the thyroid and head and neck. | 2012 Jun |
1 |
| 20 |
21782063 | Treatment of elderly patients with mantle cell lymphoma. | 2011 Jul |
1 |
| 21 |
19525224 | 14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen. | 2009 Aug 14 |
1 |
| 22 |
18603558 | Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. | 2008 Sep |
1 |
| 23 |
16624596 | In vitro studies of DNA damage and its repair in cells from NHL patients with different p53 mutant protein status, resistant (p53(+)) and sensitive (p53(-)) to cancer chemotherapy. | 2007 Jan-Feb |
1 |
| 24 |
11984085 | Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study. | 2002 Apr |
1 |
| 25 |
11762410 | Non-Hodgkin's lymphoma: review of conventional treatments. | 2001 Dec |
1 |
| 26 |
2029186 | [Similar efficacy of less than 6 and 7-10 courses of therapy with anthracycline-based combination chemotherapy for localized non-Hodgkin's lymphoma of extranodal type]. | 1991 May |
1 |
| 27 |
1703327 | [Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy]. | 1990 Aug |
1 |